Biotecnol, Digna Biotech preclinical data

In rabbit models of fulminant hepatitis, CT-1 improved survival rates vs. control

Read the full 126 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE